Charles River Laboratories International, Inc.

CRL · NYSE
Analyze with AI
12/28/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$195$277$234$245
Short-Term Investments$0$0$0$0
Receivables$721$780$752$650
Inventory$279$380$256$199
Other Curr. Assets$106$83$108$0
Total Curr. Assets$1,403$1,609$1,439$1,274
Property Plant & Equip (Net)$2,017$2,034$1,857$1,584
Goodwill$2,847$3,095$2,850$2,712
Intangibles$723$864$955$1,061
Long-Term Investments$218$244$312$201
Tax Assets$42$40$41$40
Other NC Assets$278$309$148$152
Total NC Assets$6,125$6,586$6,164$5,750
Other Assets$0$0$0$0
Total Assets$7,528$8,195$7,603$7,024
Liabilities
Payables$140$169$206$198
Short-Term Debt$0$0$0$0
Tax Payable$0$39$0$26
Deferred Revenue$248$242$264$220
Other Curr. Liab.$373$431$402$307
Total Curr. Liab.$994$1,055$1,092$1,033
LT Debt$2,240$2,647$2,708$2,917
Deferred Rev, NC$0$0$0$21
Deferred Tax Liab, NC$107$191$216$240
Other NC Liab.$195$223$175-$31
Total NC Liab.$3,026$3,481$3,488$3,399
Other Liabilities$0$0$0$0
Cap. Leases$484$419$390$289
Total Liabilities$4,020$4,536$4,579$4,432
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings$1,812$1,887$1,433$981
AOCI-$317-$196-$262-$165
Other Equity$0$0$0$0
Total Equity$3,462$3,597$2,976$2,535
Supplemental Information
Minority Interest$47$62$47$57
Total Liab. & Tot. Equity$7,528$8,195$7,603$7,024
Net Debt$2,046$2,370$2,474$2,671